Advertisement

PharmacoEconomics & Outcomes News

, Volume 819, Issue 1, pp 13–13 | Cite as

CAR-T cell therapy cost effective for paediatric B-cell ALL?

Clinical study
  • 6 Downloads

Reference

  1. Sarkar RR, et al. Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia. Journal of the National Cancer Institute : 14 Dec 2018. Available from: URL: http://doi.org/10.1093/jnci/djy193

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations